Chemoinformaics analysis of CYANIDIN-3-GALACTOSIDE-P-COUMARIC-ACID-ESTER
Molecular Weight | 234.339 | nRot | 2 |
Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
Exact Molecular Weight | 234.162 | nRing | 5 |
Solubility: LogS | -3.376 | nHRing | 0 |
Solubility: LogP | 2.532 | No. of Aliphatic Rings | 5 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 6 | No. Saturated Carbocycles | 5 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.3234 |
nHD | 1 | BPOL | 22.9386 |
QED | 0.797 |
Synth | 5.994 |
Natural Product Likeliness | 2.615 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -5.007 |
MDCK | 0.000110856 |
BBB | 0.967 |
PPB | 0.917077 |
VDSS | 0.528 |
FU | 0.0636498 |
CYP1A2-inh | 0.039 |
CYP1A2-sub | 0.763 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.933 |
CYP2c9-inh | 0.04 |
CYP2c9-sub | 0.817 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.236 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.191 |
CL | 17.747 |
T12 | 0.299 |
hERG | 0.016 |
Ames | 0.003 |
ROA | 0.576 |
SkinSen | 0.062 |
Carcinogencity | 0.111 |
EI | 0.018 |
Respiratory | 0.864 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.818321 |